CompletedPhase 1NCT02898779

Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1

Studying Malaria

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Mississippi, Oxford
Principal Investigator
Babu L Tekwani, Ph.D
University of Mississippi Medical Center
Intervention
Primaquine, R-Primaquine, S-Primaquine, SR Primaquine(drug)
Enrollment
36 target
Eligibility
18-60 years · All sexes
Timeline
2017 – 2018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02898779 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials